News / Marken expansion pushes UPS to forefront of pharma clinical trials sector

Sups healthcare
By

Clinical trials specialist and UPS-subsidiary Marken has engaged in a wave of acquisitions to boost its presence in central Europe. 

Its purchases of Austria’s Der Kurier, Hungary’s Heto and Italy’s HRTL appear to support UPS’s ambition to become a market leader in the clinical trials space. 

Marken chief executive ...

Daily News from £12 / mo  ·  includes Daily News
Subscriber Access

This is a Daily News Story

For uninterrupted access, sign in, subscribe or upgrade to The Daily News. For as little as £12 / month (£100/year), we can get you into the room where the big decisions are made.

Forgot?

Comment on this article

You must be logged in to post a comment.

    Related Stories

    Topics

    Freight Mergers Marken Merger Mania pharma focus Takeover Talk UPS